Folate deficiency may increase the risk for elevated TSH in patients with type 2 diabetes mellitus.

Lin, Lin; Du, Yushan; Niu, Guanyu; Xia, Shuangbo; Liu, Jufen

Background: Type 2 diabetes mellitus (T2DM) and thyroid dysfunction (TD) are two common chronic endocrine disorders that often coexist. Folate deficiency has been reported to be related with the onset and development of T2DM. However, the relationship between folate deficiency and TD remains unclear. This study aims to investigate the association of serum folate with TD in patients with T2DM. Methods: The study used data on 268 inpatients with T2DM in the Beijing Chao-yang Hospital, Capital Medical University from October 2020 to February 2021. Thyroid stimulating hormone (TSH), free triiodothyronine (FT3), free thyroxine (FT4), and serum folate were measured with chemiluminescence immunoassay (CLIA), and folate deficiency was defined as a serum folate concentration < 4.4 ng/mL. Ordinary least squares regression models were used to assess the association of serum folate with TSH concentration. Multivariable logistic regression models were performed to explore the correlation of folate deficiency and the risk for elevated TSH. Results: 15.3% of T2DM patients had TD. Among those patients with TD, 80.5% had elevated TSH. Compared with the normal-TSH and low-TSH groups, the prevalence of folate deficiency was significantly higher in the elevated-TSH group (P < 0.001). Serum folate level was negatively associated with TSH (β=-0.062, 95%CI: -0.112, -0.012). Folate deficiency was associated with the higher risk for elevated TSH in patients with T2DM (OR = 8.562, 95%CI: 3.108, 23.588). Conclusions: A low serum folate concentration was significantly associated with a higher risk for elevated TSH among T2DM patients.

THYROTROPIN; RESEARCH; FOLIC acid deficiency; THYROID diseases; ACADEMIC medical centers; CONFIDENCE intervals; THYROXINE; CHEMILUMINESCENCE assay; MULTIPLE regression analysis; TYPE 2 diabetes; RISK assessment; COMPARATIVE studies; IMMUNOASSAY; DESCRIPTIVE statistics; DISEASE prevalence; FOLIC acid; TRIIODOTHYRONINE; STATISTICAL correlation; ODDS ratio; DISEASE risk factors; DISEASE complications

BMC Endocrine Disorders, 2023, Vol 23, Issue 1, p1

1472-6823

Academic Journal

10.1186/s12902-023-01422-2